Haijun Chen
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 16
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 46
- Photoacoustic and Ultrasonic Imaging 9
- Molecular Biology top 5%
- Natural product bioactivities and synthesis 12
- Pharmacology top 2%
- Cancer Research top 5%
-
- Photodynamic Therapy Research Studies 17
-
- Catalytic C–H Functionalization Methods 12
- Synthesis of Indole Derivatives 7
-
- Advanced Nanomaterials in Catalysis 8
- Journals
- RSC Advances (7 papers)European Journal of Medicinal Chemistry (7 papers)Organic Letters (7 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Haijun Chen
193 papers receiving 4.8k citations
Peers
Comparison fields: 5 of 150
- Biomaterials 611
- Biomedical Engineering 1.3k
- Molecular Biology 1.9k
- Pharmacology 222
- Cancer Research 378
Countries citing papers authored by Haijun Chen
This map shows the geographic impact of Haijun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haijun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haijun Chen more than expected).
Fields of papers citing papers by Haijun Chen
This network shows the impact of papers produced by Haijun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haijun Chen. The network helps show where Haijun Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haijun Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 17 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 7 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 11 | |
| 11 | 2021 | 9 | |
| 12 | 2020 | 2 | |
| 13 | 2020 | 141 | |
| 14 | 2020 | 1 | |
| 15 | 2020 | 6 | |
| 16 | 2019 | 196 | |
| 17 | 2019 | 26 | |
| 18 | 2018 | 18 | |
| 19 | 2018 | 14 | |
| 20 | 2017 | 2 |
About Haijun Chen
Haijun Chen is a scholar working on Biomaterials, Biomedical Engineering, Toxicology, Organic Chemistry and Molecular Biology, having authored 203 papers that have together received 4.9k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (46 papers), Photodynamic Therapy Research Studies (17 papers), Nanoparticle-Based Drug Delivery (16 papers), Catalytic C–H Functionalization Methods (12 papers), Natural product bioactivities and synthesis (12 papers), Photoacoustic and Ultrasonic Imaging (9 papers), Advanced Nanomaterials in Catalysis (8 papers) and Synthesis of Indole Derivatives (7 papers). The work is most often cited by research in Biomaterials (611 citations), Biomedical Engineering (1.3k citations), Molecular Biology (1.9k citations), Pharmacology (222 citations) and Cancer Research (378 citations). Haijun Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yu Gao, Jia Zhou, Ziying Li, Xiaobin Zhou, Yilin Zheng, Biyuan Zheng, Jian‐Dong Huang, Chunyong Ding, Jinxiang Ye and Fengxiang Tang. Their work appears in journals such as RSC Advances, European Journal of Medicinal Chemistry, Organic Letters, Journal of Medicinal Chemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.